There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...

You’ve probably seen the headlines about Rebel Wilson’s incredible weight loss transformation. The actress, known for ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

And considering the rising popularity of Ozempic and other weight loss drugs, that is bound to catch folks’ attention. Toss ...

Novo Nordisk boasts 45 million customers using its drug, which has caused a revolution in weight-loss treatment. But competitors are nipping at its heels.

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

Protein takes longer to digest than simple carbohydrates and helps stabilize blood sugar levels. High-protein foods include ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.